cisapride has been researched along with Hyperaldosteronism in 3 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "patients with primary hyperaldosteronism (PH) including both aldosterone-producing adenoma and idiopathic hyperaldosteronism." | 6.68 | Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism. ( Contesse, V; Delarue, C; Dhib, M; Godin, M; Kuhn, JM; Lefebvre, H; Rieu, M; Vaudry, H; Wolf, LM, 1997) |
| "Idiopathic hyperaldosteronism (IH) is a rare disorder characterized by hypertension, hypokalemia and bilateral adrenal hypersecretion of aldosterone." | 5.31 | Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism. ( Cartier, D; Contesse, V; Delarue, C; Duparc, C; Fischmeister, R; Kuhn, JM; Lefebvre, H; Lihrmann, I; Vaudry, H, 2000) |
| "patients with primary hyperaldosteronism (PH) including both aldosterone-producing adenoma and idiopathic hyperaldosteronism." | 2.68 | Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism. ( Contesse, V; Delarue, C; Dhib, M; Godin, M; Kuhn, JM; Lefebvre, H; Rieu, M; Vaudry, H; Wolf, LM, 1997) |
| "Idiopathic hyperaldosteronism (IH) is a rare disorder characterized by hypertension, hypokalemia and bilateral adrenal hypersecretion of aldosterone." | 1.31 | Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism. ( Cartier, D; Contesse, V; Delarue, C; Duparc, C; Fischmeister, R; Kuhn, JM; Lefebvre, H; Lihrmann, I; Vaudry, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lefebvre, H | 3 |
| Dhib, M | 1 |
| Godin, M | 1 |
| Contesse, V | 3 |
| Delarue, C | 3 |
| Rieu, M | 1 |
| Wolf, LM | 1 |
| Vaudry, H | 3 |
| Kuhn, JM | 3 |
| Héron, F | 1 |
| Cartier, D | 1 |
| Duparc, C | 1 |
| Lihrmann, I | 1 |
| Fischmeister, R | 1 |
2 trials available for cisapride and Hyperaldosteronism
| Article | Year |
|---|---|
Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Cisapride; Female; Humans; Hyperald | 1997 |
Effect of the serotonin4 receptor agonist cisapride on plasma aldosterone levels in cirrhotic patients with secondary hyperaldosteronism.
Topics: Aldosterone; Cisapride; Female; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Piperidines; Sero | 1998 |
1 other study available for cisapride and Hyperaldosteronism
| Article | Year |
|---|---|
Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism.
Topics: Aldosterone; Cisapride; Female; Humans; Hyperaldosteronism; Male; Receptors, Serotonin; Receptors, S | 2000 |